Doctors are resistant to the high cost of Sorbact, leading to a refusal to discuss Cutimed.

It is not really helpful if we only look at the product cost. At the end of the day, we should look at the full cost of the therapy. Sorbact is very effective in reducing bacterial load. For example, there is a full cost analysis of the cost of surgical site infections after caesarean section. Ultimately, it is more cost effective to use Leukomed Sorbact at every caesarean section than to treat the surgical site infection. (Publications by Stanirowski and related NICE UK recommendation)